Jack A. Khattar - President, CEO, Director at SUPERNUS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO, Director
Issuer Symbol
SUPN on Nasdaq
All Insider Reports
All Insider Reports

Jack A. Khattar - trading volume in the past year for SUPERNUS PHARMACEUTICALS, INC.

Holdings reported by Jack A. Khattar for SUPERNUS PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,206,578 $62,090,503 $51.46 09 Oct 2025 Direct
Common Stock 1,005,600 $48,057,624 $47.79 09 Oct 2025 By the KBT Trust
Performance Share Unit 0 $0 $32.06 02 Oct 2025 Direct Common Stock
Performance Share Units 0 $0 $39.11 02 Oct 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 341,610 18 Feb 2026 Direct Common Stock

Transactions reported by Jack A. Khattar for SUPERNUS PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.